Intratumoral N17350 in Advanced Solid Tumors | MicrobiomeTrials← Back to trialsNCT07339176
Intratumoral N17350 in Advanced Solid Tumors
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-05-25Est. Completion: 2028-07
Enrollment target: 275 participants Locations- The Angeles Clinic and Research Institute, Los Angeles, California, United States
- UCLA - Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
- University of California, San Francisco, San Francisco, California, United States
- Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States
- The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
- Calvary Mater Hospital, Newcastle, New South Wales, Australia
- Westmead Hospital, Westmead, New South Wales, Australia
- Peter MacCallum Cancer Centre (PMCC), Melbourne, Victoria, Australia
Other microbiome trials you might be interested in
Colorectal NeoplasmsNeoplasmsIntrahepatic CholangiocarcinomaAdrenocortical CarcinomaMetastasis, Neoplasm
Background:
Cancers that begin in the colon, adrenal glands, or bile ducts may spread to the liver. These liver tumors …
Bethesda, United StatesEst. completion Dec 31, 2029
Breast CancerRelapseResistant CancerTriple Negative Breast Cancer
This phase 1, single-center, open-label study explores the safety of escalating doses of chimeric antigen receptor T cel…
Chapel Hill, United StatesEst. completion May 22, 2028
SarcomaEndocrine TumorsNeuroblastomaRetinoblastomaRenal Cancer
Background:
\- Laboratory investigators who are studying common childhood cancers are interested in developing a tissue…
Washington D.C., United States